114 related articles for article (PubMed ID: 38263609)
1. LRP8 promotes tumorigenesis in ovarian cancer through inhibiting p53 signaling.
Xu Y; Zhou Y; Yi X; Nie X
Cell Biol Int; 2024 May; 48(5):626-637. PubMed ID: 38263609
[TBL] [Abstract][Full Text] [Related]
2. Urocortin-1 promotes colorectal cancer cell migration and proliferation and inhibits apoptosis via inhibition of the p53 signaling pathway.
Guo X; Li Y; Chen X; Sun B; Guo X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):163. PubMed ID: 38546882
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA let‑7d‑5p rescues ovarian cancer cell apoptosis and restores chemosensitivity by regulating the p53 signaling pathway via HMGA1.
Chen YN; Ren CC; Yang L; Nai MM; Xu YM; Zhang F; Liu Y
Int J Oncol; 2019 May; 54(5):1771-1784. PubMed ID: 30816441
[TBL] [Abstract][Full Text] [Related]
4. miR-30b-5p inhibits cancer progression and enhances cisplatin sensitivity in lung cancer through targeting LRP8.
Qiu H; Shen X; Chen B; Chen T; Feng G; Chen S; Feng D; Xu Q
Apoptosis; 2021 Jun; 26(5-6):261-276. PubMed ID: 33779882
[TBL] [Abstract][Full Text] [Related]
5. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
6. LRP8, modulated by miR-1262, promotes tumour progression and forecasts the prognosis of patients in breast cancer.
Li L; Qu WH; Ma HP; Wang LL; Zhang YB; Ma Y
Arch Physiol Biochem; 2022 Jun; 128(3):657-665. PubMed ID: 31994910
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.
Yang Q; Yu Y; Sun Z; Pan Y
Biomed Pharmacother; 2018 Oct; 106():61-67. PubMed ID: 29957467
[TBL] [Abstract][Full Text] [Related]
8. PARP1 Is Targeted by miR-519a-3p and Promotes the Migration, Invasion, and Tube Formation of Ovarian Cancer Cells.
Chang H; Zhang X; Li B; Meng X
Cancer Biother Radiopharm; 2022 Nov; 37(9):824-836. PubMed ID: 34009012
[No Abstract] [Full Text] [Related]
9. Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network.
Jin Y; Wang H
J Ovarian Res; 2022 Jan; 15(1):3. PubMed ID: 34983607
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
Yang X; Xin N; Qu HJ; Wei L; Han Z
Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
[TBL] [Abstract][Full Text] [Related]
11. LIM domain-containing 2 (LIMD2) promotes the progress of ovarian cancer via the focal adhesion signaling pathway.
Chen L; Qian J; You Q; Ma J
Bioengineered; 2021 Dec; 12(2):10089-10100. PubMed ID: 34724866
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
13. Odd-skipped related 1 plays a tumor suppressor role in ovarian cancer via promoting follistatin-like protein 1 transcription.
Yu Z; Ouyang L
Hum Cell; 2022 Nov; 35(6):1824-1837. PubMed ID: 35964260
[TBL] [Abstract][Full Text] [Related]
14. Long non‑coding RNA NEAT1 modifies cell proliferation, colony formation, apoptosis, migration and invasion via the miR‑4500/BZW1 axis in ovarian cancer.
Xu H; Sun X; Huang Y; Si Q; Li M
Mol Med Rep; 2020 Oct; 22(4):3347-3357. PubMed ID: 32945505
[TBL] [Abstract][Full Text] [Related]
15. Silencing of lncRNA DLEU1 inhibits tumorigenesis of ovarian cancer via regulating miR-429/TFAP2A axis.
Xu H; Wang L; Jiang X
Mol Cell Biochem; 2021 Feb; 476(2):1051-1061. PubMed ID: 33170430
[TBL] [Abstract][Full Text] [Related]
16. MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression.
Zheng J; Zhou Y; Li XJ; Hu JM
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6839-6848. PubMed ID: 31486483
[TBL] [Abstract][Full Text] [Related]
17. PCAT1 promotes the proliferative and migratory potentials of ovarian cancer via targeting NEK2.
Liu XL; Liu HM; Han N; Li FH; Sun F; Fan DM; Xu Q
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8239-8248. PubMed ID: 31646554
[TBL] [Abstract][Full Text] [Related]
18. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells.
Yang X; Zhou S; Yang C; Cao C; He M; Zi S
Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876
[TBL] [Abstract][Full Text] [Related]
19. Low-density lipoprotein receptor-related protein 8 facilitates the proliferation and invasion of non-small cell lung cancer cells by regulating the Wnt/β-catenin signaling pathway.
Fang Z; Zhong M; Zhou L; Le Y; Wang H; Fang Z
Bioengineered; 2022 Mar; 13(3):6807-6818. PubMed ID: 35246020
[TBL] [Abstract][Full Text] [Related]
20. miR-183 modulated cell proliferation and apoptosis in ovarian cancer through the TGF-β/Smad4 signaling pathway.
Zhou J; Zhang C; Zhou B; Jiang D
Int J Mol Med; 2019 Apr; 43(4):1734-1746. PubMed ID: 30720057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
